— Polaris Chief Medical Officer Dr. Anne Naclerio, a retired Army veteran
GAITHERSBURG, MD, UNITED STATES, November 2, 2022 /EINPresswire.com/ — Polaris Genomics publicizes it’s a Phase II funding recipient and participant of the United States Air Force program, AFWERX Program. Over a interval operating now by the summer season of 2024, Polaris Genomics might be awarded $1.25 million as a part of AFWERX’s DoD Small Business Innovation Research (SBIR), persevering with its innovation and accelerating analysis of precision mental health solutions for developments within the screening and therapy of situations like PTSD. Notably, Polaris Genomics is amongst an esteemed 67 corporations chosen for Phase II from roughly 700 proposals obtained.
“We are honored to have been selected. The Phase II award enables us to clinically validate our PTSD screening tool across military service members to more objectively identify those with PTSD,” mentioned Polaris Chief Medical Officer Dr. Anne Naclerio, a retired Army veteran, working because the Principal Investigator for this effort. “They share our commitment to earlier diagnosis and treatment for those suffering in silence.”
The firm’s CEO Charles Cathlin can be a retired veteran and a graduate of the United States Air Force Academy, class of 1995.
ABOUT AFWERX
AFWERX is a United States Air Force program with the objective of fostering a tradition of innovation inside the service. The initiative is meant to avoid paperwork and interact new entrepreneurs in Air Force packages. The objective of the packages below the AFWERX umbrella is to develop efficient solutions to the challenges going through the service by partnerships with personal sector business entities, with explicit emphasis being positioned on collaboration with know-how startups. Learn extra at https://afwerx.com/afventures-overview/.
ABOUT POLARIS GENOMICS
Polaris Genomics is a lady, Black, and Veteran-owned biotech startup led by revered thought leaders who purpose their ardour for public health and medical analysis toward illuminating precision innovation for the good thing about the higher good.
CORE PRODUCTS & SERVICES
– TruGen-1™ is a 1000+gene panel that helps genomic analysis throughout a spectrum of neuropsychiatric situations.
– PTS-ID™ genomics take a look at gives goal data to assist clinicians confidently and rapidly assess sufferers with cortisol dysregulation related to PTSD.
– TruNorth Platform™ gives complete utilization of built-in knowledge sources to create a whole image of affected person health and PTSD danger.
– Polaris Genomics’ analysis headquarters, Endeavor Lab gives a wide range of testing or assay processing capabilities, ushering a extra in-depth understanding of neuropsychiatric situations, and enabling the event of—and entry to—precision diagnostics, health, and wellness.
Learn extra about Polaris and its staff at PolarisGenomics.com, obtain the e-newsletter & keep related at @PolarisGenomics.
Jen Williams
Polaris Genomics
+1 802-355-5072
electronic mail us right here
Visit us on social media:
Facebook
Twitter
LinkedIn
